Yi Zheng

Key Laboratory Of Chemical Biology
Jinan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Model-informed drug development in public health emergency of international concern: accelerating marketing authorization of simnotrelvir.

Model-informed drug development in public health emergency of international concern: accelerating marketing authorization of simnotrelvir.

Journal: Antimicrobial agents and chemotherapy
Published: September 18, 2025

Pharmacokinetics, Pharmacodynamics, and Safety of ET-26 in Subjects with Mild to Moderate Renal Impairment.

Pharmacokinetics, Pharmacodynamics, and Safety of ET-26 in Subjects with Mild to Moderate Renal Impairment.

Journal: Drugs in R&D
Published: August 24, 2025

CSDE1 promotes viral immune evasion through RNA-dependent and phosphorylation-modulated liquid-liquid phase separation.

CSDE1 promotes viral immune evasion through RNA-dependent and phosphorylation-modulated liquid-liquid phase separation.

Journal: Nature communications
Published: May 26, 2025

Listerin promotes α-synuclein degradation to alleviate Parkinson's disease through the ESCRT pathway.

Listerin promotes α-synuclein degradation to alleviate Parkinson's disease through the ESCRT pathway.

Journal: Science advances
Published: February 12, 2025

IDR-driven TOLLIP condensates antagonize the innate antiviral immunity by promoting the deSUMOylation of MAVS.

IDR-driven TOLLIP condensates antagonize the innate antiviral immunity by promoting the deSUMOylation of MAVS.

Journal: Cell reports
Published: August 15, 2024

Drug-drug interactions of simnotrelvir/ritonavir: an open-label, fixed-sequence, two-period clinical trial.

Drug-drug interactions of simnotrelvir/ritonavir: an open-label, fixed-sequence, two-period clinical trial.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: July 14, 2024

OTUD5 Protects Dopaminergic Neurons by Promoting the Degradation of α-Synuclein in Parkinson's Disease Model.

OTUD5 Protects Dopaminergic Neurons by Promoting the Degradation of α-Synuclein in Parkinson's Disease Model.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 17, 2024

Stress granule-localized USP8 potentiates cGAS-mediated type I interferonopathies through deubiquitination of DDX3X.

Stress granule-localized USP8 potentiates cGAS-mediated type I interferonopathies through deubiquitination of DDX3X.

Journal: Cell reports
Published: November 07, 2023

Regulation of cellular senescence by innate immunity.

Regulation of cellular senescence by innate immunity.

Journal: Biophysics reports
Published: October 30, 2023

Regulation of SARS-CoV-2 infection and antiviral innate immunity by ubiquitination and ubiquitin-like conjugation.

Regulation of SARS-CoV-2 infection and antiviral innate immunity by ubiquitination and ubiquitin-like conjugation.

Journal: Biochimica et biophysica acta. Gene regulatory mechanisms
Published: June 12, 2023

SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways.

SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways.

Journal: Journal of medical virology
Published: September 27, 2022

SARS-CoV-2 NSP8 suppresses type I and III IFN responses by modulating the RIG-I/MDA5, TRIF, and STING signaling pathways.

SARS-CoV-2 NSP8 suppresses type I and III IFN responses by modulating the RIG-I/MDA5, TRIF, and STING signaling pathways.

Journal: Journal of medical virology
Published: August 23, 2022
Showing 1-12 of 26

Last Updated: 09/26/2026